Each year an estimated 600 000 new leprosy cases are diagnosed worldwide. The spectrum of the disease varies widely from limited tuberculoid forms to extensive lepromatous forms. A measure of the risk to develop lepromatous forms of leprosy is provided by the extent of skin reactivity to lepromin (Mitsuda reaction). To address a postulated oligogenic control of leprosy pathogenesis, we investigated in the present study linkage of leprosy susceptibility, leprosy clinical subtypes, and extent of the Mitsuda reaction to six chromosomal regions carrying known or suspected leprosy susceptibility loci. The only significant result obtained was linkage of leprosy clinical subtype to the HLA/TNF region on human chromosome 6p21 (P corrected ¼ 0.00126). In addition, we established that within the same family different HLA/TNF haplotypes segregate into patients with different leprosy subtypes directly demonstrating the importance of this genome region for the control of clinical leprosy presentation.
Introduction
Leprosy is a chronic infectious disease mainly of the skin and nerves caused by the slow-growing intracellular pathogen Mycobacterium leprae. 1 The disease currently affects an estimated 1.4 million people with the majority of patients found in India and Brazil. 2 In the classical Ridley-Jopling classification 3 tuberculoid (TT) and lepromatous (LL) cases occupy the opposite ends of a continuous spectrum of disease manifestations. TT cases show involvement of few well-defined skin lesions with rare bacilli in skin and nerves and the presence of strong anti-M. leprae cell-mediated immunity. LL cases show extensive skin lesions, presence of numerous bacilli in skin and nerves, and anergy to M. leprae antigen. A clinical test to measure the quality of anti-M. leprae immune responses is the so-called 'Mitsuda' reaction to intradermally injected heat-killed M. leprae bacilli (lepromin). A positive response is indicative of low risk for developing lepromatous leprosy while lepromin unresponsiveness is found in individuals at increased risk of developing the lepromatous form of leprosy 4 . There is strong genetic epidemiological evidence that genetic factors influence susceptibility to leprosy (reviewed by Casanova and Abel. 5 ) Twin studies have shown a higher concordance rate of leprosy in monozygotic vs dizygotic twins, 6 and several complex segregation analyses have clearly shown that susceptibility to leprosy has a significant genetic component (reviewed in Abel et al 7 )
. Genetic linkage studies have provided the most convincing results in favour of the genetic hypothesis of leprosy susceptibility. The clinical leprosy subtype has been linked to the HLA region in several populations (reviewed by Meyer et al, 8 and Casanova and Abel 5 ) while leprosy per se susceptibility was found to be linked to the natural resistance associated macrophage protein 1 (NRAMP1) gene (now designated SLC11A1) 9 in Vietnamese multiplex families. The NRAMP1 gene has also been linked or associated with tuberculosis susceptibility. [10] [11] [12] Recently, the extent of Mitsuda reactivity was shown to be linked to NRAMP1, suggesting that NRAMP1 itself may control important aspects of anti-M. leprae immune responsiveness. 4 Finally, a genome-wide scan for leprosy susceptibility loci, conducted in mostly paucibacillary leprosy families, identified a locus on chromosome 10.
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Numerous association studies have also been performed using various candidate genes. Significant associations have been reported between leprosy subtypes and alleles of the vitamin D receptor gene (VDR), 14 as well as different human leukocyte antigen/tumour necrosis factor alpha gene region (HLA/TNF) alleles, including class II variants, 8, [15] [16] [17] TNF variants, 18 and TAP variants. 19 To what extent genetic heterogeneity plays a role in the genetic control of leprosy susceptibility is presently not known.
The objective of our present study was to further decipher the genetic system involved in controlling leprosy pathogenesis. In particular, we were interested in identifying susceptibility genes that would act parallel to the NRAMP1 gene in the Vietnamese population directly demonstrating the oligogenic character of leprosy susceptibility. We addressed the problem by testing six chromosomal regions, either known or suggested to carry leprosy susceptibility loci, for linkage with three different leprosy phenotypes (ie leprosy per se, leprosy subtype and extent of Mitsuda reactivity) in a group of 20 multiplex leprosy families. Specifically, we tested for a possible contribution to leprosy susceptibility of the chromosome region 10p13 suggested to carry a leprosy susceptibility gene by a recent scan, 13 the chromosome 17 region harbouring the VDR gene, 14 the HLA/TNF region on chromosome 6, 18 as well as the tumour necrosis factor receptor 1 and receptor 2 (TNFR1 and TNFR2) regions on chromosome 12 and chromosome 1, respectively, and the cytokine cluster region on chromosome 5q.
Results
The 20 nuclear families included in the study comprised 118 sibs (59 with leprosy and 59 healthy) with available phenotypes and molecular data. The distribution of the number of families according to the clinical subtypes of affected children is displayed in Table 1 . The vast majority of patients presented as tuberculoid (TT: 35%) or lepromatous (LL: 28%) cases representing the two opposite ends in the spectrum of clinical leprosy subtypes ( Figure 1a ). The extent of the Mitsuda reaction was known for all siblings and used to test for additional loci possibly involved in the genetic control of lepromin responsiveness. The distribution of the Mitsuda reaction coded as quantitative phenotype is shown in Figure 1b Linkage of the three leprosy-related phenotypes with chromosomal markers was tested using the maximumlikelihood-binomial (MLB) approach as summarized in the Subjects and methods section and results are presented in Tables 2 and 3 for single and multipoint analysis, respectively. No linkage was found between any of the genetic markers and the Mitsuda reaction coded either as a quantitative or a categorical phenotype. Analysis of the leprosy per se phenotype showed weak evidence of linkage with the TNFb microsatellite marker (Z MLB ¼ 1.83, P ¼ 0.034). However, when accounting for multiple testing this result was no more significant (P c ¼ 0.204) as confirmed by the multipoint analysis. By contrast, the analysis of leprosy subtypes found strong support of linkage of the two microsatellite markers located in the vicinity of TNF even after correcting for multiple testing (TNFa, P ¼ 0.00056, P c ¼ 0.00336 and TNFb, P ¼ 0.00073, P c ¼ 0.00438). The absence of linkage with the TNF promoter allele was likely due to the very low information content (IC) for this marker (IC: 0.12). To increase the IC, we performed a multipoint linkage analysis assuming a recombination fraction of zero between TNFa, TNFb and TNF(À308) promoter marker. As expected, no recombination was found between the three markers. Hence, multilocus linkage analysis allowed the construction of TNF haplotypes for each family. Since segregation of these haplotypes was analysed in two-generational families, occurrence of recombination between TNF and the tightly linked class I and class II genes was unlikely allowing the TNF haplotypes to serve as markers for the segregation of the entire HLA region. Multilocus analysis increased the evidence for linkage between leprosy subtypes and the TNF/HLA region (
To further investigate the linkage between leprosy subtypes and the TNF/HLA region, we performed an 1TT+2BL+2LL  13  3  3TT  18  5  1TT+1I+3BL  20  2  1TT+1I  25  3  1TT+2LL  26  3  1I+2LL  28  3  2TT+1LL  35  3  2TT+1LL  44  4  3TT+1I  48  3  1TT+2BB  50  2  2LL  53  3  3LL  59  2  1BB+1LL  61  3  3TT  62  3  1TT+1BB+1LL  69  3  1BT+2BB  70  2  1TT+1LL  74  2  2BB  77  2  1BB+1LL  78  4 additional analysis on a sample including only extreme phenotypes, ie LL and TT patients. This subset comprised 12 families with 32 siblings with extreme phenotypes (15 LL and 17 TT). Not surprisingly, since these extreme phenotypes contributed strongly to the overall likelihood of linkage, the results were very consistent with those observed in the whole sample. In particular, single-point corrected P-values for TNFa and TNFb were 0.0033 and 0.0022, respectively, while multipoint analysis of the TNF/HLA region led to a P c of 0.0042. In the case of extreme phenotypes, it can be shown that there is a direct relationship between a (ie the probability parameter of the binomial distributions as defined in the Statistical methods section) and the proportion of alleles shared by siblings with the same extreme phenotype, which is equal to 1À2a(1Àa). Therefore, the proportion of parental alleles shared by LL sibs or by TT sibs is estimated at 0.774. Symmetrically the estimated proportion of alleles shared by discordant sibs (one LL and one TT) is 0.226. An illustration of this non-random segregation of HLA/TNF haplotypes into LL and TT patients in the same family is presented in Figure 2 .
Discussion
Three phenotypes that reflect different aspects of leprosy pathogenesis were chosen for genetic analysis: leprosy per se, leprosy type and extent of Mitsuda skin reactivity also called lepromin reactivity. The latter phenotype is of interest since lepromin reactivity has been linked to risk of developing the LL form of the disease and to present type I reversal reactions. 20 Type I reversal hypersensitivity reactions in turn are a major cause of nerve function impairment in leprosy. 1 Linkage of these three susceptibility phenotypes to six chromosomal regions was tested in 20 multiplex leprosy families. In the same families, we had previously detected a genetic effect of the NRAMP1 chromosomal region on chromosome region 2q35 on leprosy susceptibility 9 and extent of the Mitsuda test. 4 None of the candidate regions showed significant evidence for linkage with immune responsiveness as measured by the lepromin skin test. Especially unexpected was the lack of linkage to the HLA/TNF region since it is widely believed that HLA alleles are major genetic control elements of anti-mycobacterial immunity. By contrast, we had previously detected a strong impact of the NRAMP1 chromosomal region on the same immune response. 4 The example of the genetic control of lepromin reactivity shows clearly that major genetic trigger mechanisms of anti-mycobacterial immune responses can be located outside of the HLA/TNF complex as previously suggested by other studies. 21 Likewise, when employing leprosy per se as phenotype, no significant evidence for linkage with any of the tested chromosomal regions was observed. Absence of linkage of leprosy susceptibility to the cytokine cluster region on human chromosome 5q is noteworthy. This region has been linked with susceptibility to infection levels in schistosomiasis 22 and malaria, 23 suggesting a major gene controlling Th1/Th2 balance of immune responsiveness was located in this region. Our data show that such a gene plays little role-if any-in the pathogenesis of leprosy in the families analysed in our experiments despite the Th1/Th2 nature of TT vs LL disease. 16, 24 Also, the complete absence of linkage of leprosy susceptibility to the VDR-carrying chromosome 17 region and to chromosome region 10p13 suggests that loci located in these regions do not have a major genetic effect on leprosy susceptibility in our families. Finally, there was borderline evidence in favour of a leprosy per se susceptibility locus in the HLA/TNF region (P uncorr ¼ 0.034). However, when correcting the P-value for multiple testing and performing multipoint analysis, this result was no more significant. This negative finding is consistent with previous reports showing that HLA haplotypes segregated randomly among affected 25 and healthy 26 siblings in multicase leprosy families, suggesting that HLA has little effect on susceptibility to leprosy per se.
The most exciting finding of the present study was the strong linkage of the HLA/TNF region with leprosy type. Clinical manifestations of leprosy have been associated or linked with the HLA/TNF region in multiple studies (reviewed by Meyer et al, 8 and Casanova and Abel 5 ). Non-random segregation of parental HLA haplotypes was observed among sets of children with TT leprosy from Surinam, 27 Central 27 and South 25 India, Venezuela 26 , and Egypt. 28 Similar results were obtained for siblings with LL leprosy from Venezuela 26 and China. 29 All these studies, however, have focused on one leprosy subtype, ie they have shown that HLA haplotypes do not segregate randomly in families including either TT or LL cases but not both. Since the families enrolled in our study are made up of sibships displaying different clinical types of leprosy, it was possible for the first time to directly establish that within the same family different HLA/TNF haplotypes segregate into patients with differential disease manifestations. This is a new and strong argument for the implication of this region in the clinical outcome that follows M. leprae infection. Together with our previous findings that leprosy per se is linked to the NRAMP1 gene region in the same families, the present results provide direct experimental evidence for a two-stage genetic model of leprosy susceptibility: non-HLA linked genes such as NRAMP1 control susceptibility to disease per se, ie these genes control advancement from innocuous infection or carrier status to clinically evident disease, while HLA-linked loci control the subtype of leprosy disease. The present study detected non-random segregation of HLA/TNF haplotypes into patients with different forms of leprosy. Due to the close linkage of TNF with HLA class I and class II genes it is not possible to conclude to any specific gene as cause of the observed segregation distortion. The best known polymorphism impacting on TNF biological activity is the TNFÀ308 G/A SNP. Hence, the non-significant linkage results with leprosy subtypes obtained for the TNF À308 promoter and TNFR polymorphisms argue against a major role of TNF alleles in the pathogenetic processes that eventually lead to different clinical presentations of leprosy. From these considerations, we conclude that the biased segregation of the HLA/TNF region into offspring with different clinical forms of leprosy within the same family is mainly caused by HLA region genes other than TNF, most likely HLA class II gene variants.
Subjects and methods

Families
The nuclear families studied correspond to the sample identified from records of the Dermatology Hospital in Ho Chi Minh city and used previously to perform a linkage analysis with the NRAMP1 gene. 4, 9 This family sample includes 20 nuclear families (118 children, 59 with leprosy) with at least two siblings affected by leprosy. The ratio of Vietnamese (16 families 
Phenotype definition
Diagnosis of leprosy was made by at least two independent and experienced leprologists following physical examination of each patient (in particular the number and appearance of skin lesions, presence or absence of anaesthesia, and an evaluation of peripheral nerves were recorded) and standard histopathologic examination of affected skin lesions. As the patient cohort contained multibacillary cases, microbiologic confirmation of clinical and histopathologic diagnosis via acid-fast bacilli was possible in approximately half of the patients. Clinical subtype was defined according to the five-group system of Ridley and Jopling. 3 All Mitsuda reactions were performed by experienced Vietnamese leprologists, and were read 28-30 days after the intradermal injection of 0.1 ml of lepromin in the volar surface of the forearm. Mitsuda reaction was measured in 118 children (including healthy individuals) belonging to 20 nuclear families with sibship sizes ranging from 2 to 12. However, because of computational constraints, the maximum number of sibs per family was limited to nine. Therefore, for the two families with 10 and 12 sibs, we removed the youngest and the three youngest unaffected sibs, respectively. For further analyses, the delayed lepromin reaction was first considered as a quantitative trait, ranging from 0 to 14 mm. We also coded the Mitsuda reaction as a four class categorical trait: o3 mm, [3-5 mm],]5-10 mm[, and X10 mm. Cutting points 3 and 5 mm are defined following the recommendations of the Sixth International Leprosy Congress held in Madrid (1953) , and the last one (ie 10 mm) as later suggested by Languillon. 30 A Mitsuda reaction o3 mm is classically considered as negative whereas a reaction X10 mm is clearly positive.
Genotyping
Of the 16 markers used in the study, 13 were microsatellite repeat markers and three were single nucleotide polymorphisms (SNP).
Microsatellites: Primer sequences for markers TNFa and TNFb located within the HLA Class III region 3.5 Kb upstream the TNF-b (LTA) gene, and the Tnfr1 marker located in intron 1 of the tumour necrosis factor receptor superfamily, member 1A (TNFRS1A, TNFR1, TNFRp55, CD120a) gene were described by Udalova 31 and Eskdale 32 , respectively. The microsatellite markers TNFa and TNFb are anonymous DNA repeat markers and do not designate allotypes for the TNF (TNF) and TNF-b (LTA) genes. The markers on chromosomal region 10p13 (D10S586, D10S1653, D10S1661, D10S1662, D10S582, D10S1660) have been described elsewhere. 13 Marker positions and primer sequences for marker D12S368 located 5.2 Mb downstream of the VDR gene, theTnfr2 marker D1S434 located 200 kb downstream to the tumour necrosis factor receptor superfamily, member 1B (TNFRS1B, TNFR2, TNFRp75/80, CD120b) and the two microsatellite markers D5S658 and D5S393 located in proximity to the cytokine cluster on human chromosome region 5q31-q33 were obtained from the Whitehead Institute for Biomedical Research (http://www-genome.-wi.mit.edu/). All microsatellite markers used in this study were amplified under uniform PCR conditions. Briefly, the final composition of the reaction mixture contained 20 ng of genomic template DNA, 1.5 mm MgCl 2 , 0.2 mm dNTPs, 0.1 mm of each forward and reverse primers and 1.0 U of Taq DNA Polymerase (Gibco BRL). Thermal cycling was done in a PTC-100 Programmable Thermal Controller (MJ Research Inc.). The reaction was initiated by denaturing the samples at 961C for 5 min, followed by 35 cycles of 1 min each denaturation at 941C, primer annealing at 551C and extension at 721C. The final extension was done at 721C for 10 min. Fragment sizing was performed by polyacrylamide gel (6%) electrophoresis. To assure unambiguous identification of parental microsatellite alleles segregating among the family offspring, amplified fragments of the same microsatellite for all family members were always run next to each other on the same gel.
SNP: Two SNP located at nucleotide position 1056 in the 3 0 end and nucleotide position 117 in exon 2 of the VDR gene (accession number XM_007046; markers VDR-1056 and VDR-117, respectively) were assessed by PCR-RFLP. The VDR-1056 C/T SNP region was amplified using primers described by Roy et al. 14 The resulting amplification product was digested with 1.5 units of TaqI restriction enzyme for 6 h at 651C, and the allelic composition at the VDR-1056 locus was obtained by fragment sizing on a 2.5% agarose gel. The VDR-117 T/C SNP was genotyped using primers and conditions as described by Scott et al. 33 Finally, the TNF-(À308) G/A SNP was genotyped by means of a 5 0 nuclease assay 34, 35 employing the forward primer, 5 0 CCAAAAGAAATGGAGGCAAT3 0 , the reverse primer, 5 0 GCCACTGACTGATTTGTGTGT3 0 , and 5'FAM-CCGT CCCCATGCCCCTCAAA-TAMRA3 0 and 5'TET-CCG TCCTCATGCCCCTCAAA-TAMRA3 0 as allele-specific oligonucleotides. The calling of the genotypes was based on the FAM/TET ratio as read in a Perkin-Elmer LS-5B fluorescence spectrometer with 5 nm slit widths.
Statistical methods
Linkage analysis was performed using the MLB approach which can handle binary (ie affected vs not affected), categorical (leprosy subtypes and categorical Mitsuda) and quantitative (quantitative Mitsuda) phenotypes. 4 . In addition to the possibility of analysing several types of phenotype, this method provides three interesting properties that were requested here: (i) it is a genetic model-free linkage analysis method, ie we do not have to specify the underlying genetic model which, in the context of leprosy, remains unknown; (ii) it does not need to decompose sibships into its constitutive sibpairs, a process which is known to inflate the type I error rate (eg see Holmans 36 ), and 18 out of our 20 families contain more than two sibs; (iii) in the context of quantitative phenotypes, the MLB is not sensitive to the phenotypic distribution (in particular it does not assume multivariate normality) as shown by large simulation studies 37 .
To analyse the binary leprosy per se phenotype (affected/not affected), we used the MLB approach for binary traits. 38, 39 The MLB linkage test is a likelihood ratio test which can be expressed as a one-sided standard normal statistic denoted as Z MLB .
Analysis of quantitative and categorical traits was performed using the corresponding extensions of the MLB method. 40, 41 These extensions are based on the introduction of an individual latent binary variable {0;1} which captures the linkage information between the observed quantitative trait and the marker. In the context of Mitsuda phenotypes (coded as quantitative or categorical), a value of 0 (respectively 1) for this binary variable can be understood as an 'absolute' negative (respectively positive) Mitsuda result. The method needs to specify the probability of the latent variable value (ie having a negative or a positive reaction) according to the observed phenotype. For the analysis of the quantitative Mitsuda we used a standard cumulative normal distribution as proposed in by Alcais and Abel. 40 For the analysis of the categorical Mitsuda we fixed the probability to have a 0 value at 1, 0.75, 0.25 and 0 for phenotypes belonging to the first (o3 mm), second([3-5 mm]), third (]5-10 mm[) and fourth (X10 mm) class, respectively, as already suggested in a previous study. 4 For leprosy subtype we used the same approach as for categorical Mitsuda phenotype. In this case, the value 0 can be understood as an 'absolute' tuberculoid case, and symmetrically the value 1 corresponds to an 'absolute' lepromatous case. We fixed the probability to have a 0 value at 1, 0.75, 0.5, 0.5, 0.25 and 0 for TT, borderline tuberculoid (BT) borderline borderline (BB), indeterminate (I), borderline lepromatous (BL) and LL, respectively (therefore, for individuals BB or I, the probability to be TT equals the probability to be LL, ie 0.5). Again, the test for linkage is a likelihood ratio test expressed as a one-sided standard normal deviate, denoted Z MLBQ and Z MLBC for quantitative and categorical phenotypes, respectively.
Multipoint linkage analysis was performed using an extension of the previous methods that has been implemented in an extended GENEHUNTER program 42 available upon request. Finally, to account for multiple comparisons, we corrected the observed P-values by means of the Bonferroni correction. Since six independent regions were investigated (HLA/TNF region, chromosome region 5q, TNFR regions, chromosome 10p region and VDR region), the corrected p-value (denoted as p c ) was six times the observed P-value (eg an observed P-value of 0.01 corresponds to a P c of 0.06).
